Identification of DLAT as a potential therapeutic target via a novel cuproptosis-related gene signature for the prediction of liver cancer prognosis
Cuproptosis-related genes contribute to tumor development and can aid the prediction of LC patient prognosis. <i>DLAT</i> is a potential LC prognostic and therapeutic target.
Authors
- Tong Shen (ORCID: https://orcid.org/0000-0001-8558-2086)
- Cunbing Xia
- Yongkang Zhu (ORCID: https://orcid.org/0000-0001-9123-7158)
- Vasileios Mavroeidis (ORCID: https://orcid.org/0000-0002-8188-3575)
- Dexuan Chen (ORCID: https://orcid.org/0000-0001-6596-8184)
- Vishal G. Shelat (ORCID: https://orcid.org/0000-0003-3988-8142)
- Giovanni Battista Levi Sandri (ORCID: https://orcid.org/0000-0002-7893-5047)
- Hai‐Jian Sun (ORCID: https://orcid.org/0000-0002-7791-5335)
- Yang Chen (ORCID: https://orcid.org/0000-0003-4347-4217)
- Zhan Wang (ORCID: https://orcid.org/0000-0002-1335-4698)
- Hong Zhu (ORCID: https://orcid.org/0000-0002-3635-0067)
Institutions
- North Bristol NHS Trust (GB)
- Nanjing University of Chinese Medicine (CN)
- Tan Tock Seng Hospital (SG)
- Agostino Gemelli University Polyclinic (IT)
- Central Hospital of Zibo (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/jgo-24-609
- Citations
- 5
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Nanjing University of Chinese Medicine
- Nanjing University